Calcineurin inhibitor-associated impairment of COX-2 signaling in kidney cortex is restored by angiotensin II receptor blocker
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Dissertation, 2021
- Keyword
-
Kidney cortex
Disabilities
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (when)
-
2021
- Creator
- DOI
-
10.17169/refubium-30712
- URN
-
urn:nbn:de:kobv:188-refubium-30974-3
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hu, Junda
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Time of origin
- 2021
Other Objects (12)
Renin-angiotensin system blockers and COVID-19
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Calcineurin
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Synaptic disruption and CREB‐regulated transcription are restored by K + channel blockers in ALS
Synaptic disruption and CREB‐regulated transcription are restored by K+ channel blockers in ALS
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
Renin-angiotensin system blockers and COVID-19
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Calcineurin
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Synaptic disruption and CREB‐regulated transcription are restored by K + channel blockers in ALS
Synaptic disruption and CREB‐regulated transcription are restored by K+ channel blockers in ALS
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
Renin-angiotensin system blockers and COVID-19
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Calcineurin
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Synaptic disruption and CREB‐regulated transcription are restored by K + channel blockers in ALS
Synaptic disruption and CREB‐regulated transcription are restored by K+ channel blockers in ALS
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis